Covid-19 vaccine: Volunteers of Sputnik V trial to no longer receive placebos
Live MintVolunteers of the large-scale final-stage trials for the Sputnik V will not receive placebos anymore, said the vaccine's developer Gamaleya Institute in Moscow on Wednesday. "The Health Ministry had authorised a halt to the administration of placebos to new recruits to the stage III trial," said Alexander Ginsburg, the institute's director. Interim data results Data published last week by the Gamaleya Institute had revealed that the Sputnik V vaccine is 91.4% effective in protecting people against Covid-19. According to the protocol of Phase III clinical trials of the Sputnik V vaccine, its interim efficacy is calculated at three statistically significant representative control points - upon reaching 20, 39 and 78 cases of novel coronavirus infection among volunteers both in the placebo group and in the group that received the vaccine, the Gamaleya Institute said.